Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat

This publication has 13 references indexed in Scilit:

• Diminished Cardioprotective Response to Inhibition of Angiotensin-Converting Enzyme and Angiotensin II Type 1 Receptor in B₂Kinin Receptor Gene Knockout Mice
  Circulation Research, 2001
• Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction
  Journal of the American College of Cardiology, 2001
• Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
  The Lancet, 2000
• Vasopeptidase Inhibition with Omapatrilat Improves Cardiac Geometry and Survival in Cardiomyopathic Hamsters More Than Does ACE Inhibition with Captopril
  Journal of Cardiovascular Pharmacology, 1999
• Novel Neurohormonal Modulators in Cardiovascular Disorders
  Drugs in R&D, 1999
• Chronic Dual Inhibition of Angiotensin-Converting Enzyme and Neutral Endopeptidase During the Development of Left Ventricular Dysfunction in Dogs
  Journal of Cardiovascular Pharmacology, 1998
• Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat.
  Circulation, 1998
• Inhibition of Neutral Endopeptidase Causes Vasoconstriction of Human Resistance Vessels In Vivo
  Circulation, 1998
• Quantitation of Changes in the Expression of Multiple Genes by Simultaneous Polymerase Chain Reaction
  Analytical Biochemistry, 1993
• Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1992